Stereotaxis EBITDA 2010-2025 | STXS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Stereotaxis ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Stereotaxis ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185.9B
Thermo Fisher Scientific (TMO)	$156.6B
Edwards Lifesciences (EW)	$44.9B
Alcon (ALC)	$43.1B
IDEXX Laboratories (IDXX)	$41.4B
DexCom (DXCM)	$32.9B
IQVIA Holdings (IQV)	$27.8B
Mettler-Toledo (MTD)	$24.8B
STERIS (STE)	$22.2B
SONOVA HOLDING (SONVY)	$17.4B
Waters (WAT)	$17.1B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.4B
Globus Medical (GMED)	$7.6B
Glaukos (GKOS)	$5.6B
Teleflex (TFX)	$4.9B
Integer Holdings (ITGR)	$3.9B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.3B
Elekta AB (EKTAY)	$1.9B
Nihon Kohden (NHNKY)	$1.9B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.5B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1B